Anthera Pharmaceuticals, Inc. (ANTH)

0.0001 0.00 (0.00%) USD  |  OTCM  |  Sep 25, 16:00
More

Anthera Pharmaceuticals Price to Book Value

Price to Book Value Chart

View Price to Book Value for ANTH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to Book Value Chart
Start Trial

Historical Price to Book Value Data

View and export this data back to 2010. Start Trial.
Date Value
September 25, 2026 0.0005
September 24, 2026 0.0005
September 23, 2026 0.00
September 22, 2026 0.00
September 21, 2026 0.00
September 18, 2026 0.00
September 17, 2026 0.00
September 16, 2026 0.00
September 15, 2026 0.00
September 14, 2026 0.00
September 11, 2026 0.00
September 10, 2026 0.00
September 09, 2026 0.00
September 08, 2026 0.00
September 04, 2026 0.00
September 03, 2026 0.00
September 02, 2026 0.00
September 01, 2026 0.00
August 31, 2026 0.00
August 28, 2026 0.00
August 27, 2026 0.00
August 26, 2026 0.0005
August 25, 2026 0.0005
August 24, 2026 0.0005
August 21, 2026 0.0005
Date Value
August 20, 2026 0.0005
August 19, 2026 0.0005
August 18, 2026 0.0005
August 17, 2026 0.0005
August 14, 2026 0.0005
August 13, 2026 0.0005
August 12, 2026 0.0005
August 11, 2026 0.0005
August 10, 2026 0.0005
August 07, 2026 0.0005
August 06, 2026 0.0005
August 05, 2026 0.00
August 04, 2026 0.00
August 03, 2026 0.0005
July 31, 2026 0.0005
July 30, 2026 0.0005
July 29, 2026 0.0005
July 28, 2026 0.0005
July 27, 2026 0.0005
July 24, 2026 0.0005
July 23, 2026 0.0005
July 22, 2026 0.0005
July 21, 2026 0.0005
July 20, 2026 0.0005
July 17, 2026 0.0005

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Windtree Therapeutics, Inc. --
FluoroPharma Medical, Inc. --
GlobeStar Therapeutics Corp. --
MultiCell Technologies, Inc. --
RegeneRx Biopharmaceuticals, Inc. --

Price to Book Value Related Metrics

Price 0.0001
Market Cap 0.0026M